Literature DB >> 23235745

Mast cell chymase modulates IL-33 levels and controls allergic sensitization in dust-mite induced airway inflammation.

I Waern1, A Lundequist, G Pejler, S Wernersson.   

Abstract

Mast cells (MCs) are major effector cells contributing to allergic conditions. When activated, they can release large amounts of active proteases, including chymase from their secretory granules. Here we assessed the role of the chymase mouse mast cell protease 4 (mMCP-4) in allergic airway inflammation induced by house-dust mite (HDM) extract. mMCP-4-/-) mice demonstrated elevated airway reactivity and eosinophilia compared with wild-type (WT) animals, suggesting a protective role for mMCP-4 during the late inflammatory phase of the disease. However, mMCP-4 also contributed to the sensitization phase, as indicated by higher levels of serum immunoglobulin E in mMCP-4(-/-) vs. WT mice and higher levels of cytokines secreted by HDM-restimulated mMCP-4(-/-) vs. WT splenocytes. In line with a contribution of mMCP-4 in the early stages of disease, HDM extract directly induced chymase secretion from MCs. The elevated airway and inflammatory responses of mMCP-4(-/-) mice were associated with a profound increase in the levels of interleukin (IL)-33 in the lung tissue. Moreover, WT MCs degraded IL-33 more efficiently than did MCs lacking mMCP-4. Together, our findings identify a protective role of a MC chymase in a physiologically relevant model for airway inflammation and suggest that chymase-mediated regulation of IL-33 can account for this protective function.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23235745     DOI: 10.1038/mi.2012.129

Source DB:  PubMed          Journal:  Mucosal Immunol        ISSN: 1933-0219            Impact factor:   7.313


  36 in total

Review 1.  Approaches for analyzing the roles of mast cells and their proteases in vivo.

Authors:  Stephen J Galli; Mindy Tsai; Thomas Marichal; Elena Tchougounova; Laurent L Reber; Gunnar Pejler
Journal:  Adv Immunol       Date:  2015-02-07       Impact factor: 3.543

2.  TGF-β1 Suppresses IL-33-Induced Mast Cell Function.

Authors:  Victor S Ndaw; Daniel Abebayehu; Andrew J Spence; Patrick A Paez; E Motunrayo Kolawole; Marcela T Taruselli; Heather L Caslin; Alena P Chumanevich; Anuya Paranjape; Bianca Baker; Brian O Barnstein; Tamara T Haque; Kasalina N Kiwanuka; Carole A Oskeritzian; John J Ryan
Journal:  J Immunol       Date:  2017-06-21       Impact factor: 5.422

Review 3.  Mast cell proteases as pharmacological targets.

Authors:  George H Caughey
Journal:  Eur J Pharmacol       Date:  2015-05-07       Impact factor: 4.432

Review 4.  Potential effector and immunoregulatory functions of mast cells in mucosal immunity.

Authors:  L L Reber; R Sibilano; K Mukai; S J Galli
Journal:  Mucosal Immunol       Date:  2015-02-11       Impact factor: 7.313

Review 5.  Mast cell secretory granules: armed for battle.

Authors:  Sara Wernersson; Gunnar Pejler
Journal:  Nat Rev Immunol       Date:  2014-06-06       Impact factor: 53.106

6.  Central domain of IL-33 is cleaved by mast cell proteases for potent activation of group-2 innate lymphoid cells.

Authors:  Emma Lefrançais; Anais Duval; Emilie Mirey; Stéphane Roga; Eric Espinosa; Corinne Cayrol; Jean-Philippe Girard
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-13       Impact factor: 11.205

Review 7.  Mast cells as sources of cytokines, chemokines, and growth factors.

Authors:  Kaori Mukai; Mindy Tsai; Hirohisa Saito; Stephen J Galli
Journal:  Immunol Rev       Date:  2018-03       Impact factor: 12.988

Review 8.  Novel Insight into the in vivo Function of Mast Cell Chymase: Lessons from Knockouts and Inhibitors.

Authors:  Gunnar Pejler
Journal:  J Innate Immun       Date:  2020-06-04       Impact factor: 7.349

Review 9.  Mast cell chymase: morphofunctional characteristics.

Authors:  Dmitri Atiakshin; Igor Buchwalow; Markus Tiemann
Journal:  Histochem Cell Biol       Date:  2019-08-08       Impact factor: 4.304

Review 10.  Formation of nasal polyps: The roles of innate type 2 inflammation and deposition of fibrin.

Authors:  Tetsuji Takabayashi; Robert P Schleimer
Journal:  J Allergy Clin Immunol       Date:  2020-03       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.